MA42268A - Compositions antimicrobiennes contenant des cannabinoïdes - Google Patents

Compositions antimicrobiennes contenant des cannabinoïdes

Info

Publication number
MA42268A
MA42268A MA042268A MA42268A MA42268A MA 42268 A MA42268 A MA 42268A MA 042268 A MA042268 A MA 042268A MA 42268 A MA42268 A MA 42268A MA 42268 A MA42268 A MA 42268A
Authority
MA
Morocco
Prior art keywords
compositions containing
antimicrobial compositions
containing cannabinoids
cannabinoids
antimicrobial
Prior art date
Application number
MA042268A
Other languages
English (en)
Inventor
George Anastassov
Lekhram Changoer
Damme Phillipus Van
Original Assignee
Axim Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axim Biotechnologies Inc filed Critical Axim Biotechnologies Inc
Publication of MA42268A publication Critical patent/MA42268A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A01N31/16—Oxygen or sulfur directly attached to an aromatic ring system with two or more oxygen or sulfur atoms directly attached to the same aromatic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA042268A 2015-06-23 2016-06-21 Compositions antimicrobiennes contenant des cannabinoïdes MA42268A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562183573P 2015-06-23 2015-06-23

Publications (1)

Publication Number Publication Date
MA42268A true MA42268A (fr) 2018-05-02

Family

ID=57585447

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042268A MA42268A (fr) 2015-06-23 2016-06-21 Compositions antimicrobiennes contenant des cannabinoïdes

Country Status (5)

Country Link
US (3) US20160374958A1 (fr)
EP (1) EP3313394A4 (fr)
HK (1) HK1254812A1 (fr)
MA (1) MA42268A (fr)
WO (1) WO2016209802A1 (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3352855A4 (fr) 2015-09-22 2019-05-22 Vitality Biopharma, Inc. Promédicaments à base de glycosides cannabinoïdes et méthodes de synthèse
US10053407B2 (en) * 2016-06-01 2018-08-21 S&B Pharma, Inc. Crystalline cannabidivarin
US20190255014A1 (en) * 2016-11-07 2019-08-22 Avidas Pharmaceuticals Llc Therapeutic Cannabinoid Formulations and Methods for Their Use
WO2018148786A1 (fr) * 2017-02-15 2018-08-23 Botanix Pharmaceuticals Ltd Formulations de cannabinoïdes pour le traitement de l'acné
US20220323401A1 (en) * 2017-02-15 2022-10-13 Botanix Pharmaceuticals Ltd. Formulations of cannabinoids for the treatment of acne
JP2020508991A (ja) * 2017-02-15 2020-03-26 ボタニクス ファーマシューティカルズ リミテッド 乾癬の処置のためのカンナビノイドの製剤
JP7012089B2 (ja) * 2017-02-15 2022-01-27 ボタニクス ファーマシューティカルズ リミテッド 皮膚炎および炎症性皮膚疾患の処置のためのカンナビノイドの製剤
WO2018148785A1 (fr) * 2017-02-15 2018-08-23 Botanix Pharmaceuticals Ltd Formulations de cannabinoïdes pour le traitement de la dermatite et de maladies cutanées inflammatoires
WO2018148787A1 (fr) * 2017-02-15 2018-08-23 Botanix Pharmaceuticals Ltd Formulations de cannabinoïdes pour le traitement du psoriasis
US20210128518A1 (en) * 2017-03-06 2021-05-06 Jack D. Korbutov Cannabinoid-containing dermatological compositions and methods using same
EP3606343A1 (fr) 2017-04-04 2020-02-12 Gojo Industries Inc Procédés et composés permettant d'augmenter l'efficacité virucide dans des systèmes hydroalcooliques
WO2018208875A1 (fr) 2017-05-09 2018-11-15 Vitality Biopharma, Inc. Compositions antimicrobiennes comprenant des cannabinoïdes et leurs méthodes d'utilisation
US12324789B2 (en) * 2017-08-28 2025-06-10 Apirx Pharmaceutical Usa, Llc Method to treat psoriasis
US10272051B2 (en) * 2017-08-28 2019-04-30 Axim Biotechnologies, Inc. Method to treat atopic dermatitis
CN109498605B (zh) * 2017-09-15 2020-12-01 汉义生物科技（北京）有限公司 一种治疗妇科炎症的组合物及其在外用组合物中的应用
WO2019144191A1 (fr) * 2018-01-24 2019-08-01 Botanix Pharmaceuticals Ltd Régime de dosage de cannabinoïde pour le psoriasis
WO2019144190A1 (fr) * 2018-01-24 2019-08-01 Botanix Pharmaceuticals Ltd Régime de dosage de cannabinoïde pour dermatite et affections cutanées inflammatoires
CN112020352A (zh) * 2018-01-24 2020-12-01 博塔尼克斯制药有限公司 用于痤疮的大麻素给药方案
US20210052544A1 (en) * 2018-01-29 2021-02-25 Solantech Inc. Methods of treating and/or preventing bedsores using nabilone
WO2019210210A1 (fr) * 2018-04-27 2019-10-31 Thomas Jefferson University Matériaux à base de chanvre nanofilés
WO2019244160A1 (fr) * 2018-06-20 2019-12-26 Tel Ari Ruben Compositions hyperosmotiques antimicrobiennes non irritantes contenant du cannabidiol
WO2020000024A1 (fr) * 2018-06-28 2020-01-02 Botanix Pharmaceuticals Ltd Traitement antibactérien utilisant des combinaisons de cannabinoïdes
WO2020024056A1 (fr) * 2018-08-01 2020-02-06 Lazar Eve Compositions comprenant des cannabinoïdes et matériau absorbable et utilisations associées
CA3111979A1 (fr) * 2018-09-05 2020-03-12 Nemus Bioscience, Inc. Cannabinoides pour le traitement d'infections a gram positif comprenant des souches bacteriennes antibioresistantes
US20210379010A1 (en) * 2018-10-30 2021-12-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions comprising cannabinoids for use in the treatment of biofilm and conditions associated with microbial, fungal, bacterial infections
WO2020180969A1 (fr) * 2019-03-05 2020-09-10 Colleen Smith Compositions vétérinaires et procédés d'utilisation associés
US20220296535A1 (en) * 2019-06-18 2022-09-22 Botanix Pharmaceuticals Limited Antibacterial Dosage Regime Using Cannabinoids
WO2020257588A1 (fr) * 2019-06-20 2020-12-24 Shaman Naturals, Llc Compositions pour la prévention et le traitement d'infections virales
CN110283050A (zh) * 2019-07-01 2019-09-27 大兴安岭林格贝寒带生物科技股份有限公司 利用超高压技术富集纯化大麻二酚的方法
US20210177740A1 (en) * 2019-12-11 2021-06-17 Joel Studin Transpore delivery of cannabinoid and uses thereof
US11590187B2 (en) * 2020-01-14 2023-02-28 Shaman Naturals, Llc Antimicrobial compositions
US20230094265A1 (en) * 2020-01-30 2023-03-30 Innocan Pharma Ltd. Compositions for hemorrhoid treatment
WO2021188886A1 (fr) * 2020-03-20 2021-09-23 Credo Science, Llc Compositions antimicrobiennes et procédés
CN111557900B (zh) * 2020-05-22 2023-05-12 广州大洲生物医药科技有限公司 大麻二酚乳膏剂，其制备方法及用途
GB202010268D0 (en) * 2020-07-03 2020-08-19 Novabiotics Ltd Nail formulations and treatment regimes
US12097458B2 (en) * 2020-08-07 2024-09-24 John Bohde Mold and fungal (mycotoxin) toxin remediation
WO2022077271A1 (fr) * 2020-10-14 2022-04-21 Huang Yu Fen Flavonoïdes polymères et leur utilisation
US20220125755A1 (en) * 2020-10-24 2022-04-28 Kevin Hazen Cannabis time release apparatus and method of manufacture thereof
EP4297876A1 (fr) * 2021-02-23 2024-01-03 Pharmotech SA Compositions biocides et leurs utilisations
US20230085692A1 (en) * 2021-08-18 2023-03-23 P2 Science, Inc. Cannabis species as industrial chemical feedstocks
US12337054B2 (en) 2022-04-01 2025-06-24 TF Holdings LLC Skin treatment composition containing cannabinoids
US20240041901A1 (en) 2022-08-02 2024-02-08 TF Holdings LLC Wound treatment topical composition containing cannabinoids
US20240148762A1 (en) 2022-11-09 2024-05-09 TF Holdings LLC Topical composition containing cannabinoids

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411883A (en) * 1973-02-05 1983-10-25 Colgate-Palmolive Company Antiperspirant
US5223244A (en) * 1988-06-20 1993-06-29 Shiseido Company, Ltd. Aerosol composition
US5780020A (en) * 1996-10-28 1998-07-14 The Proctor & Gamble Company Methods and compositions for reducing body odor
US7025992B2 (en) * 2001-02-14 2006-04-11 Gw Pharma Limited Pharmaceutical formulations
US20040229939A1 (en) * 2003-02-14 2004-11-18 Chowdhury Dipak K. Tetrahydrocannabinol compositions and methods of manufacture and use thereof
CA2522231A1 (fr) * 2003-04-14 2004-10-21 Vectura Ltd Compositions pharmaceutiques comprenant de l'apomorphine pour l'inhalation pulmonaire
AU2013213706B2 (en) * 2005-11-07 2016-04-14 Murty Pharmaceuticals, Inc An improved oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
US20100130603A1 (en) * 2007-03-09 2010-05-27 Kyoto University Medicament for prophylactic and therapeutic treatment of dermatosis resulting from excessively advanced keratinization
GB2450493A (en) * 2007-06-25 2008-12-31 Gw Pharma Ltd Cannabigerol for use in treatment of diseases benefiting from agonism of CB1 and CB2 cannabinoid receptors
US8222292B2 (en) * 2007-08-06 2012-07-17 Insys Therapeutics, Inc. Liquid cannabinoid formulations
EP2424568A1 (fr) * 2009-04-29 2012-03-07 University Of Kentucky Research Foundation Compositions contenant un cannabinoïde et leurs méthodes d'utilisation
PT2473475T (pt) * 2009-08-31 2017-08-02 Zynerba Pharmaceuticals Inc Utilização de profármacos de canabidiol na administração tópica e transdérmica com microagulhas
WO2013009928A1 (fr) * 2011-07-11 2013-01-17 Organic Medical Research Formulations de cannabinoïdes

Also Published As

Publication number Publication date
EP3313394A1 (fr) 2018-05-02
US10441552B2 (en) 2019-10-15
US20160374958A1 (en) 2016-12-29
US20190209487A1 (en) 2019-07-11
US20200016095A1 (en) 2020-01-16
US11058646B2 (en) 2021-07-13
WO2016209802A1 (fr) 2016-12-29
HK1254812A1 (zh) 2019-07-26
EP3313394A4 (fr) 2019-02-27

Similar Documents

Publication Publication Date Title
EP3313394A4 (fr) Compositions antimicrobiennes contenant des cannabinoïdes
ME03003B (fr) Compositions comprenant des souches bactériennes
PT3355990T (pt) Compostos semifluorados e as suas composições
DK3240414T3 (da) Fungicide sammensætninger
EP3503875A4 (fr) Compositions hydrosolubles comprenant des cannabinoïdes purifiés
DK3361870T3 (da) Fungicidsammensætninger
MA41212A (fr) Composition de soin oral contenant des cannabinoïdes
EP3236978C0 (fr) Composition antimicrobienne
EP3407855A4 (fr) Compositions antioxydantes stables
DK3892302T3 (da) Sammensætninger indeholdende ibrutinib
BR112017001922A2 (pt) composições fungicidas
BR112016030366A2 (pt) composição antimicrobiana sinergística de piritiona de zinco
EP3360546A4 (fr) Composition solide contenant un polyphénol
FR3041503B1 (fr) Projectiles oxodegradables contenant des pheromones
EP3315430A4 (fr) Contenant
DK3253485T3 (da) No-holdige sammensætninger
EP3500102C0 (fr) Composition antimicrobienne
EP3897732A4 (fr) Composition contenant des cannabinoïdes
PL3261437T3 (pl) Grzybobójcze związki i kompozycje
EP3443078A4 (fr) Compositions antimicrobiennes
EP3458041A4 (fr) Compositions antibactériennes
DK3451829T3 (da) Antimikrobielle sammensætninger
FR3020948B1 (fr) Composition antimicrobienne
MA44601A (fr) Composition ophtalmique contenant de la pvp-i
DK3393967T3 (da) Antimikrobiel polymersammensætning